Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Enact Holdings, Inc. (Nasdaq: ACT) SEC filings, offering a detailed view of how the U.S. private mortgage insurance provider reports its financial condition, capital structure and material events. As a public company headquartered in Raleigh, North Carolina and operating through Enact Mortgage Insurance Corporation, Enact uses its filings to disclose information that is central to understanding its mortgage insurance business.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Enact’s discussion of primary insurance in-force, new insurance written, loss experience, capital sufficiency relative to Private Mortgage Insurer Eligibility Requirements, and the impact of reinsurance and credit facilities. Current reports on Form 8-K supplement these periodic filings by describing specific events, such as the announcement of quarterly financial results or the entry into a senior unsecured revolving credit facility.
Enact’s filings also include details on its credit risk transfer activities, including quota share and excess of loss reinsurance agreements with panels of highly rated reinsurers. These documents explain how portions of expected new insurance written for future book years are covered and how such arrangements affect risk and capital management. The credit agreement filed as an exhibit to an 8-K outlines the terms of the revolving credit facility, including financial covenants tied to consolidated net worth, debt-to-total capitalization and PMIERs compliance.
On Stock Titan, SEC documents for ACT are updated in near real time as they are posted to the EDGAR system. AI-powered summaries help interpret complex sections of 10-Ks, 10-Qs and 8-Ks by highlighting key points about earnings, capital, reinsurance structures and covenants. Users can also review insider and executive transaction reports on Form 4, along with proxy and governance filings, with AI-generated explanations that clarify how these disclosures relate to Enact’s mortgage insurance operations and its relationship with majority owner Genworth Financial, Inc.
Enact Holdings director Debra Still received 168 deferred stock units on 09/08/2025, increasing her beneficial ownership to 30,378.457 units. The filing shows these units were acquired as deferred stock units (DSUs) and were credited pursuant to reinvestment terms from a dividend paid on 09/08/2025 at $0.21 per share. The DSUs are payable in shares of common stock one year after termination of service as a director, and the reported price for the acquisition is recorded as $0. The transaction was reported on a Form 4 filed 09/10/2025 and was executed under power of attorney.
Enact Holdings insider reported receipt of restricted stock units (RSUs) by Mitchell Hardin Dean, EVP, CFO and Treasurer. On 09/08/2025 Mr. Dean was awarded or received additional RSUs that will settle 1:1 into common stock. The filing lists three RSU transactions of 38, 67 and 82 units credited on 09/08/2025 related to dividend reinvestment terms at a dividend of $0.21 per share paid the same day. Each RSU converts to one share of common stock when vested; the reported beneficial ownership following each reported transaction is 7,057, 12,445 and 15,115 shares, respectively. The RSU grants have staggered vesting schedules: vesting in three equal annual installments beginning on 02/09/2024, 02/16/2025 and 02/21/2026 for the respective awards. The Form 4 is signed by a power of attorney on behalf of the reporting person on 09/10/2025.
Enact Holdings, Inc. (ACT) Form 4 discloses deferred stock unit awards and reinvestment activity for director Dominic James Addesso. On 09/08/2025, 292 Deferred Stock Units were acquired, and additional deferred stock units were credited under reinvestment terms from a dividend paid on 09/08/2025 at $0.21 per share. Following the reported transactions, the filing shows 8,723.163 shares held directly and deferred, plus 24,177 shares held indirectly by Deborah Addesso and 20,650 shares held indirectly by D.J. Addesso Holdings, LLC. The deferred stock units become payable in common shares one year after termination of service as a director.
Enact Holdings executive Brian Gould, EVP & Chief Operations Officer, acquired a total of 63 restricted stock units (RSUs) on 09/08/2025 that will settle 1:1 into common shares of Enact Holdings (ticker: ACT). The filing lists three separate RSU awards of 14, 22 and 27 units, each shown with a $0 per-share price because they are restricted units rather than open-market purchases. The report also notes additional RSUs were granted pursuant to reinvestment terms tied to a quarterly dividend of $0.21 per share. The RSUs have staged vesting schedules that convert to common stock in three equal annual installments starting on specified February dates for each award.
Michael A. Bless, a director of Enact Holdings, Inc. (ACT), acquired 145 deferred stock units on 09/08/2025. The units were recorded as an acquisition under a director award and were credited due to reinvestment of a dividend paid on 09/08/2025 at $0.21 per share. The deferred stock units are payable in shares of common stock one year after the director’s termination of service. Following the reported transaction the filing shows beneficial ownership of 26,350.538 shares held directly.
Enact Holdings director Westley V. Thompson received 168 Deferred Stock Units (DSUs) on 09/08/2025, which are payable in common stock one year after termination of director service. The DSUs were credited via reinvestment of a dividend valued at $0.21 per share. After this accrual, the reporting person beneficially owns 30,378.457 shares of common stock on a direct basis. The Form 4 reports the grant as a non‑derivative acquisition with no cash exercise price.
Enact Holdings, Inc. (ACT) reported insider awards for Rohit Gupta, President and CEO and director. On 09/08/2025 Mr. Gupta was issued three tranches of restricted stock units (RSUs) that will settle 1:1 into common shares: 171 RSUs, 201 RSUs and 245 RSUs. Each tranche reports a $0 price reflecting grant/reinvestment terms tied to a quarterly dividend of $0.21 per share paid on 09/08/2025.
The filing shows the reported beneficial ownership following these issuances as 31,593, 37,333 and 45,340 shares respectively for the three RSU lines. Vesting schedules are specified: the first tranche vests in three equal annual installments beginning 02/09/2024, the second beginning 02/16/2025 and the third beginning 02/21/2026. The Form 4 is signed by a power of attorney on 09/10/2025.
Enact Holdings insider transaction: Genworth Holdings, Inc., a reporting person and the company's majority shareholder, sold 648,312 shares of Enact Holdings common stock on 08/29/2025 at a per-share price of $37.1842. The sale was effected pursuant to a Share Repurchase Agreement between Enact and Genworth dated April 30, 2025, a copy of which is available in the issuer's SEC filings at the provided link. After this reported disposition, Genworth Holdings beneficially owns 118,873,450 shares, representing approximately 81% of Enact's outstanding common stock. The Form 4 was signed by Lisa J. Baldyga, Vice President and Treasurer, on behalf of Genworth Holdings, Inc.
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025. The filings show dispositions of 11,039, 17,856 and 4,000 shares, respectively, at weighted-average sale prices of $38.18, $37.59 and $37.73 per share. Following the transactions, the reporting person beneficially owned 369,755 shares. The Form 4 is signed by a power of attorney for the reporting person.
Enact Holdings, Inc. (ACT) filed a Form 144 disclosing a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC on 08/27/2025 on the NYSE. The filing reports an aggregate market value of $749,140 for the proposed sale and shows 410,433,925 shares outstanding.
The shares were acquired as compensation: 59,080 shares on 03/25/2024 and 27,326 shares on 03/01/2024. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.